Closed
1.76 -1.68
24h
Min
1.664
Max
1.776
Income | -25M |
---|---|
Sales | 12M |
Profit margin | -200.599 |
Employees | 181 |
EBITDA | -26M |
Recommendations | Buy |
---|---|
12 Months Forecast | +155.61% upside |
Market Cap | 144M |
---|---|
Previous open | 3.44 |
Previous close | 1.76 |
By Trading Central
Confidence
Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.397 EUR 155.61%
High 5.7 EUR
Low 3.1 EUR
Based on 2 Wall Street analysts offering 12 month price targets forInnate Pharma SA - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$